New Approach to Diabetes Based on Microneedle Smart Patch Insulin Delivery
By LabMedica International staff writers Posted on 02 Feb 2017 |
Image: Tiny, painless microneedles on a patch can deliver insulin in response to rising glucose levels (Photo courtesy of the ACS).
A novel "microneedle smart patch" has been developed that was designed to automatically correct glucose imbalance in patients with type I or advanced type II diabetes.
An interdisciplinary team of investigators at North Carolina State University and the University of North Carolina designed a smart patch comprising microneedles made from block copolymer incorporated with polyethylene glycol (PEG) and phenylboronic ester (PBE)-conjugated polyserine.
The device, which integrated H2O2-responsive polymeric vesicles (PVs) with a transcutaneous microneedle-array patch, were loaded with the enzyme glucose oxidase (GOx) and insulin. The microneedles functioned as both moieties of the glucose sensing element (GOx) and the insulin release actuator to provide basal insulin release as well as promote insulin release in response to hyperglycemic states.
Results reported in the current study, which was published in the January 4, 2017, online edition of the journal ACS Nano, revealed that insulin release responded quickly to elevated glucose and that its kinetics could be modulated by adjusting the concentration of GOx loaded into the microneedles. Using a mouse diabetes model, the investigators showed that a single patch could regulate glucose levels effectively with reduced risk of hypoglycemia.
An interdisciplinary team of investigators at North Carolina State University and the University of North Carolina designed a smart patch comprising microneedles made from block copolymer incorporated with polyethylene glycol (PEG) and phenylboronic ester (PBE)-conjugated polyserine.
The device, which integrated H2O2-responsive polymeric vesicles (PVs) with a transcutaneous microneedle-array patch, were loaded with the enzyme glucose oxidase (GOx) and insulin. The microneedles functioned as both moieties of the glucose sensing element (GOx) and the insulin release actuator to provide basal insulin release as well as promote insulin release in response to hyperglycemic states.
Results reported in the current study, which was published in the January 4, 2017, online edition of the journal ACS Nano, revealed that insulin release responded quickly to elevated glucose and that its kinetics could be modulated by adjusting the concentration of GOx loaded into the microneedles. Using a mouse diabetes model, the investigators showed that a single patch could regulate glucose levels effectively with reduced risk of hypoglycemia.
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples